<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22260" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Glaucoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dietze</surname>
            <given-names>Jamie</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Blair</surname>
            <given-names>Kyle</given-names>
          </name>
          <aff>Advocate Lutheran General Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zeppieri</surname>
            <given-names>Marco</given-names>
          </name>
          <aff>University Hospital of Udine, Italy</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Havens</surname>
            <given-names>Shane J.</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jamie Dietze declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kyle Blair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Zeppieri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shane Havens declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22260.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Glaucoma is a complex eye condition characterized by elevated intraocular pressure (IOP) that may&#x000a0;progress to vision loss over time. This eye condition is categorized into primary or secondary types and further&#x000a0;into open-angle or closed-angle variants. Adult glaucoma includes primary open-angle glaucoma (POAG) and angle-closure glaucoma, as well as&#x000a0;secondary open and angle-closure glaucoma, with a specific focus on the most prevalent type, POAG.&#x000a0;Researchers are investigating genetic and environmental factors contributing to glaucoma development.</p>
        <p>Although the available treatments cannot cure existing optic nerve damage or reverse visual field loss, they can help control the disease progression through medication, laser treatment, or incisional glaucoma surgeries to help prevent further vision loss.&#x000a0;These treatments aim to lower IOP and mitigate the impact of this vision-threatening condition through an interprofessional healthcare team for optimal treatment outcomes.&#x000a0;This activity reviews various forms of glaucoma, including congenital, infantile, developmental, and juvenile variants, emphasizing cases primarily affecting individuals aged 40 and older. This activity also highlights the collaborative approach involving an interprofessional healthcare team for glaucoma management due to its impact on vision. Early detection and regular monitoring are crucial for effectively managing glaucoma&#x02014;the second leading cause of permanent blindness among older adults in the United States.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the early signs and risk factors associated with glaucoma, including elevated intraocular pressure, optic nerve changes, and visual field defects.</p></list-item><list-item><p>Screen patients at risk for glaucoma during routine eye examinations, including those with a family history, advanced age, diabetes, and other relevant medical conditions.</p></list-item><list-item><p>Apply imaging modalities such as optical coherence tomography and visual field testing in glaucoma diagnosis, monitoring, and management.</p></list-item><list-item><p>Collaborate with interprofessional healthcare providers to provide comprehensive glaucoma care, ensure timely interventions,&#x000a0;optimize outcomes, and prevent irreversible vision loss in patients with glaucoma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22260&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22260">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22260.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Glaucoma is a complex eye condition characterized by elevated intraocular pressure (IOP) that may&#x000a0;progress to vision loss over time. Glaucoma is the second leading cause of permanent blindness in the United States and occurs most often in older adults.<xref ref-type="bibr" rid="article-22260.r1">[1]</xref>&#x000a0;Glaucoma can be&#x000a0;categorized into either primary or secondary types and further&#x000a0;into open-angle or closed-angle variants within&#x000a0;each type of glaucoma.&#x000a0;Adult glaucoma includes primary open-angle glaucoma (POAG) and angle-closure glaucoma, as well as&#x000a0;secondary open and angle-closure glaucoma,<xref ref-type="bibr" rid="article-22260.r2">[2]</xref><xref ref-type="bibr" rid="article-22260.r3">[3]</xref> with a specific focus on the most prevalent type, POAG.<xref ref-type="bibr" rid="article-22260.r4">[4]</xref><xref ref-type="bibr" rid="article-22260.r5">[5]</xref>&#x000a0;</p>
        <p>Glaucoma is an acquired loss of retinal ganglion cells and axons within the optic nerve or optic neuropathy that results in a characteristic optic nerve head appearance and a corresponding progressive loss of vision.<xref ref-type="bibr" rid="article-22260.r6">[6]</xref> This unique pattern of peripheral vision loss serves as a distinguishing feature from other types of vision impairment.<xref ref-type="bibr" rid="article-22260.r7">[7]</xref>&#x000a0;</p>
        <p>Patients with POAG&#x000a0;are often asymptomatic until significant optic nerve damage occurs unless early signs of glaucoma are identified during routine eye examinations.<xref ref-type="bibr" rid="article-22260.r8">[8]</xref> On the other hand, acute angle-closure glaucoma can develop suddenly and lead to a rapid decline in vision, accompanied by symptoms such as corneal edema, eye pain, headache, nausea, and emesis.<xref ref-type="bibr" rid="article-22260.r9">[9]</xref><xref ref-type="bibr" rid="article-22260.r10">[10]</xref> Secondary glaucoma often arises due to a previous eye injury or underlying medical conditions, resulting in elevated IOP and subsequent optic neuropathy. This category encompasses various subtypes, including congenital, pigmentary, neovascular, exfoliative, traumatic, and uveitic glaucoma.<xref ref-type="bibr" rid="article-22260.r11">[11]</xref> Normal or low-tension type of glaucoma presents as an optic neuropathy with glaucomatous visual loss despite normal or unremarkable IOP readings.<xref ref-type="bibr" rid="article-22260.r12">[12]</xref></p>
        <p>Although congenital, infantile, and developmental glaucoma, along with a juvenile variant of POAG, primarily affect younger individuals, most types of glaucoma are commonly diagnosed in individuals aged 40 and older. While IOP is often associated with glaucoma, a direct causal relationship has not been definitively established. Researchers are investigating genetic and environmental factors contributing to glaucoma development. Evidence from studies involving monozygotic twin pairs, who exhibit a higher concordance rate compared to dizygotic pairs, suggests that environmental factors also have a significant role in the disease's development.<xref ref-type="bibr" rid="article-22260.r13">[13]</xref>&#x000a0;</p>
        <p>Although the available treatments cannot cure existing optic nerve damage or reverse visual field loss, they can help control the disease progression through medication, laser treatment, or incisional glaucoma surgeries to prevent further vision loss. All therapeutic interventions are focused on lowering IOP and minimizing the impact of this vision-threatening condition. This approach aims to prevent the onset of glaucoma in patients with risk factors and to manage the condition effectively to limit its progression in affected individuals.</p>
      </sec>
      <sec id="article-22260.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiology of glaucoma is unknown, but a clear correlation with elevated eye pressure exists in most cases. High IOP is the primary risk factor for developing glaucoma and for the progression of the disease, and it is also the sole factor that current treatments can effectively address.<xref ref-type="bibr" rid="article-22260.r14">[14]</xref></p>
        <p>
<bold>Primary Open-Angle Glaucoma</bold>
</p>
        <p>POAG typically manifests as slow, painless damage to the optic nerve due to an ineffective drainage system in the eye. In glaucoma, the resistance to drainage of aqueous humor most commonly starts at the inner wall of Schlemm canal at the juxtacanalicular trabecular meshwork. This decreased outflow facility or increased resistance to aqueous outflow results in a gradual rise in IOP, leading to characteristic damage patterns in the visual field and the optic nerve ganglion cell nerve fiber layer.<xref ref-type="bibr" rid="article-22260.r15">[15]</xref> Recent studies have highlighted that elevated IOP can also reduce blood flow to the optic nerve fibers, resulting in subtle ischemic damage (see <bold>Image.&#x000a0;</bold>Glaucomatous Optic Nerve Head Showing Inferotemporal Retinal Nerve Fiber Layer Defect).<xref ref-type="bibr" rid="article-22260.r16">[16]</xref></p>
        <p>POAG patients often have elevated IOP readings correlating with characteristic optic nerve damage and visual field defect patterns (see<bold>&#x000a0;Image.&#x000a0;</bold>Glaucoma Visual Field Changes in the Left Eye). As the disease progresses, a slow loss of peripheral vision in one or typically both eyes eventually leads to loss of central vision. Because of this loss pattern, affected persons do not notice a change in their vision until their loss is advanced and affects the central vision, in which case damage is permanent and irreversible.<xref ref-type="bibr" rid="article-22260.r7">[7]</xref>&#x000a0;</p>
        <p>Glaucoma can manifest at different ages, with the age of onset often characterizing its presentation. Although POAG is typically associated with adulthood, it can also affect younger individuals and children, suggesting a significant genetic component. Primary congenital glaucoma is diagnosed in newborns aged up to 1 month, often suspected when there is eye enlargement at birth.<xref ref-type="bibr" rid="article-22260.r17">[17]</xref> Infantile glaucoma affects individuals between the ages of 1 and 36 months,<xref ref-type="bibr" rid="article-22260.r18">[18]</xref> while juvenile glaucoma is used to indicate individuals diagnosed with glaucoma between the ages of 3 and 40.<xref ref-type="bibr" rid="article-22260.r19">[19]</xref> Juvenile open-angle glaucoma shares similarities with POAG in terms of IOP leading to optic nerve damage, but it occurs in a younger age group with higher IOP levels and potentially more severe visual field defects.<xref ref-type="bibr" rid="article-22260.r20">[20]</xref></p>
        <p>
<bold>Low-Tension or Normal-Tension Glaucoma</bold>
</p>
        <p>This type of glaucoma resembles POAG in terms of characteristic optic disc cupping and peripheral visual-field loss findings.<xref ref-type="bibr" rid="article-22260.r16">[16]</xref> However, what sets it apart is that IOP readings are consistently normal, typically measuring less than 21 mmHg.<xref ref-type="bibr" rid="article-22260.r12">[12]</xref> Theories suggest that patients with this type of glaucoma may have an optic nerve that is abnormally sensitive to pressure or may experience intermittent ischemic changes due to atherosclerosis or vascular insufficiency. These patients often exhibit a higher prevalence of migraines, Raynaud phenomenon, autoimmune diseases, ischemic vascular diseases, and coagulopathies. This observation may suggest the involvement of a vascular autoregulatory defect in the pathogenesis of the disease.<xref ref-type="bibr" rid="article-22260.r21">[21]</xref><xref ref-type="bibr" rid="article-22260.r22">[22]</xref><xref ref-type="bibr" rid="article-22260.r23">[23]</xref><xref ref-type="bibr" rid="article-22260.r24">[24]</xref>&#x000a0;In addition, these patients tend to have a greater frequency of nerve fiber layer hemorrhages and a neuroretinal rim that is thinner inferiorly and inferotemporal than those with POAG. Visual field defects in this type of glaucoma are typically more focal, deeper, and closer to fixation rather than following the classic arcuate scotoma pattern seen in open-angle glaucoma.<xref ref-type="bibr" rid="article-22260.r25">[25]</xref></p>
        <p>
<bold>Angle-Closure Glaucoma</bold>
</p>
        <p>Angle-closure glaucoma is classified based on ocular anatomy and can manifest as a medical emergency in the acute setting or as a chronic condition.<xref ref-type="bibr" rid="article-22260.r26">[26]</xref> In the acute form, this type of glaucoma occurs when the eye's drainage system is abruptly blocked due to the closure of the angle formed between the cornea and the iris.<xref ref-type="bibr" rid="article-22260.r27">[27]</xref>&#x000a0;Typically, this blockage arises from age-related lens thickening, leading to a gradual increase in a relative pupillary block that pushes the iris anteriorly. This anteriorly displaced iris, coupled with a natural anatomical variation such as a smaller angle seen in hypermetropia or specific ethnic groups, predisposes easier blockage of the outflow tract.<xref ref-type="bibr" rid="article-22260.r28">[28]</xref></p>
        <p>A pupillary block is considered the underlying cause in the majority of cases.<xref ref-type="bibr" rid="article-22260.r29">[29]</xref> When sudden pupil dilation occurs due to certain stimuli, darkness, or drugs, the iris&#x000a0;is thick enough in its contracted state or anteriorly displaced by pupillary block to block fluid drainage via the trabecular meshwork. The pressure rapidly increases within the eye. This rapid change in&#x000a0;IOP can cause central and/or peripheral vision loss within a few days of onset without intervention and very high IOP. A significantly elevated IOP and acute angle closure can lead to complications such as retinal vascular occlusion, ischemic optic neuropathy, or glaucomatous optic nerve damage. However, it is important to note that only about 10% of glaucoma cases fall into the acute angle-closure type category.<xref ref-type="bibr" rid="article-22260.r30">[30]</xref></p>
        <p>Angle-closure glaucoma can also occur as a secondary condition due to various causes. Examples include lens subluxation in Marfan syndrome,<xref ref-type="bibr" rid="article-22260.r31">[31]</xref>&#x000a0;lens dislocation,<xref ref-type="bibr" rid="article-22260.r32">[32]</xref>&#x000a0;and lens-induced glaucoma.<xref ref-type="bibr" rid="article-22260.r33">[33]</xref>&#x000a0;The&#x000a0;displacement of the lens into the pupil or anterior chamber can lead to an acute pupillary block.<xref ref-type="bibr" rid="article-22260.r34">[34]</xref> Plateau&#x000a0;iris configuration can also cause an acute pupillary block and chronic angle closure, attributed to elongated or anteriorly positioned ciliary processes pushing the iris edges forward.<xref ref-type="bibr" rid="article-22260.r35">[35]</xref><xref ref-type="bibr" rid="article-22260.r36">[36]</xref> In iridocorneal endothelial syndrome, irregular corneal endothelium migration onto the trabecular meshwork and peripheral iris can lead to high peripheral anterior synechiae, closing the angle and hindering outflow.<xref ref-type="bibr" rid="article-22260.r37">[37]</xref><xref ref-type="bibr" rid="article-22260.r38">[38]</xref></p>
        <p>Neovascularization can cause angle closure in neovascular glaucoma by forming a fibrovascular membrane that flattens and displaces the iris anteriorly. This process, along with new vessel formation in the iris and angle in rubeosis iridis, can lead to total synechial closure of the angle.<xref ref-type="bibr" rid="article-22260.r39">[39]</xref> The most common etiologies of neovascular glaucoma are central retinal or branch retinal vein occlusion, proliferative diabetic retinopathy, and ocular ischemic syndrome.<xref ref-type="bibr" rid="article-22260.r40">[40]</xref>&#x000a0;Angle-closure glaucoma can also occur post-ophthalmic surgery due to factors such as ciliary body edema, scleral buckle placement, fibrin deposition, gas, or silicone oil used in retinal surgery.<xref ref-type="bibr" rid="article-22260.r41">[41]</xref> Additionally, sulfa drugs such as topiramate can induce angle closure by causing ciliochoroidal effusion, which compresses the lens-iris diaphragm and anteriorly displaces it, resulting in angle closure.<xref ref-type="bibr" rid="article-22260.r42">[42]</xref></p>
        <p>
<bold>Secondary Open-Angle Glaucoma</bold>
</p>
        <p>Secondary open-angle glaucoma can result from various factors such as eye injury, eye disease, and occasionally eye surgery. These conditions can elevate IOP, leading to optic nerve damage and functional defects similar to those seen in primary open-angle glaucoma. One notable mechanism of secondary open-angle glaucoma arises from laser surgery, which can trigger pigment release, inflammatory cell accumulation, debris deposition, and mechanical deformation. These factors can collectively obstruct the trabecular meshwork, contributing to elevated IOP levels (see <bold>Image. </bold>Hypermature Morgagnian Cataract).</p>
        <p><bold>Pseudoexfoliation Glaucoma</bold>&#x000a0;</p>
        <p>Pseudoexfoliation syndrome (PEX) is a type of glaucoma characterized by the presence of flaky material within the anterior chamber of the eye that collects in the angle. This material can clog the trabecular meshwork, leading to increased resistance to aqueous outflow and elevated IOP.<xref ref-type="bibr" rid="article-22260.r43">[43]</xref> PEX syndrome is a systemic disorder affecting the extracellular matrix, with ocular manifestations such as white deposits on the pupil's margin and the anterior capsule of the lens, which can occur in one or both eyes.<xref ref-type="bibr" rid="article-22260.r44">[44]</xref> This secondary form of open-angle glaucoma poses additional risks during cataract surgery, including zonular dialysis, capsular bag rupture, and vitreous loss. These risks are attributed to eyes with unstable lens zonules and poor pupillary dilation associated with PEX syndrome.<xref ref-type="bibr" rid="article-22260.r45">[45]</xref></p>
        <p>Individuals with pigment dispersion syndrome (PDS) are at an increased risk of elevated IOP.<xref ref-type="bibr" rid="article-22260.r46">[46]</xref> Ocular&#x000a0;manifestations of PDS share similarities with PEX syndrome, except that in PDS, the debris consists of pigment granules from the posterior iris surface. These granules can detach and obstruct the trabecular meshwork, especially in myopic or near-sighted eyes, due to contact with the peripheral lens capsule and zonules.<xref ref-type="bibr" rid="article-22260.r47">[47]</xref> Features of PDS include anterior chamber pigment dispersion, spoke-like iris defects on trans-illumination, central corneal endothelial deposits (known as the Krukenberg spindle), and increased pigmentation in the iridocorneal angle.<xref ref-type="bibr" rid="article-22260.r48">[48]</xref> Some individuals may progress to pigment dispersion glaucoma or pigmentary glaucoma characterized by elevated IOP levels, glaucomatous optic neuropathy, and/or visual field defects.<xref ref-type="bibr" rid="article-22260.r49">[49]</xref></p>
        <p>
<bold>Steroid-Induced Glaucoma</bold>
</p>
        <p>Steroid-induced glaucoma can occur in susceptible individuals undergoing cortisone therapy due to glucocorticoid's effects. Glucocorticoids can upregulate receptors on cells within the trabecular meshwork, leading to increased outflow resistance. Additionally, the accumulation of glycosaminoglycans in the meshwork pores contributes to this resistance.<xref ref-type="bibr" rid="article-22260.r50">[50]</xref> Steroids can also suppress phagocytic activity, which decreases debris deposition removal from the meshwork and stimulates the expression of extracellular matrix proteins.<xref ref-type="bibr" rid="article-22260.r51">[51]</xref></p>
        <p>Another form of secondary glaucoma is a carotid-cavernous fistula, characterized by an abnormal connection between the cavernous sinus and the carotid artery.<xref ref-type="bibr" rid="article-22260.r52">[52]</xref> This condition causes arterial flow and venous engorgement, leading to elevated episcleral venous pressure. The consequent dilation of retinal veins and swelling of the optic disc can cause concurrent damage to optic nerve fibers.<xref ref-type="bibr" rid="article-22260.r53">[53]</xref></p>
        <p>Secondary glaucoma can also result from posttraumatic or postoperative conditions, elevated episcleral venous pressure, and tumor-related factors.<xref ref-type="bibr" rid="article-22260.r54">[54]</xref> Ellingson syndrome, also known as uveitis-glaucoma-hyphema syndrome, is a complication that can cause elevated IOP following the implantation of an intraocular lens. This elevation in IOP can occur either immediately after surgery or manifest years later as a complication.<xref ref-type="bibr" rid="article-22260.r55">[55]</xref></p>
        <p>Glaucomatocyclitic crisis, also known as Posner-Schlossman syndrome, presents with recurrent acute episodes of elevated IOP that typically resolve spontaneously without treatment. However, repeated episodes have been associated with glaucomatous damage to the optic nerve over time (see <bold>Image.&#x000a0;</bold>Advanced Glaucomatous Damage to the Optic Nerve).<xref ref-type="bibr" rid="article-22260.r56">[56]</xref><xref ref-type="bibr" rid="article-22260.r57">[57]</xref><xref ref-type="bibr" rid="article-22260.r58">[58]</xref></p>
      </sec>
      <sec id="article-22260.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Glaucoma is a condition marked by the gradual loss of peripheral vision and irreversible damage to the optic nerve and retinal ganglion cells, making it a significant public health concern. Its multifactorial etiology involves anatomical, genetic, vascular, and immune factors. Glaucoma is a fundamental public health concern, considering that, after cataracts, it is the second cause of irreversible blindness. Currently affecting over 60 million individuals worldwide, this number is expected to surpass 110 million by 2040.<xref ref-type="bibr" rid="article-22260.r59">[59]</xref>&#x000a0;POAG is the most prevalent type, affecting approximately 2% to 4% of individuals aged 40 and older and around 10% of those aged 75 and older.<xref ref-type="bibr" rid="article-22260.r60">[60]</xref></p>
        <p>The African population exhibits the highest prevalence of open-angle glaucoma. Individuals of African descent face up to a 15-fold increased risk of blindness from open-angle glaucoma compared to other population groups.<xref ref-type="bibr" rid="article-22260.r7">[7]</xref>&#x000a0;On&#x000a0;the other hand, the Inuit population has the highest prevalence of angle-closure glaucoma. Women are more commonly affected than men in this group, along with individuals of Asian descent, who generally have a shallower anterior chamber, contributing to the higher rates of angle closure.<xref ref-type="bibr" rid="article-22260.r61">[61]</xref>&#x000a0;The normal-tension type of glaucoma is most prevalent in Japanese populations.</p>
        <p>Age represents a significant risk factor in the progressive loss of retinal ganglion cells across all types of glaucoma. Additionally, other risk factors for developing glaucoma include a family history of the condition in a primary relative (mother, father, brother, sister, or children) and medical conditions such as diabetes, high blood pressure, and heart disease. Eye trauma, anatomical differences such as thinner corneas, a history of retinal detachment, eye tumors or inflammation, and prolonged use of corticosteroids are also associated with an increased risk of glaucoma.<xref ref-type="bibr" rid="article-22260.r62">[62]</xref></p>
      </sec>
      <sec id="article-22260.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The optic nerve carries over 1 million nerve fibers that transmit visual signals from the photoreceptors in the outer retina to the visual processing areas of the occipital lobe. Damage to the retinal nerve fiber layer occurs in various types of glaucoma. Aqueous humor, the fluid in the anterior chamber of the eye, is crucial in maintaining intraocular pressure and nourishing ocular tissues. Aqueous humor is produced by the non-pigmented epithelial cells of the ciliary body processes and follows a circadian production pattern.<xref ref-type="bibr" rid="article-22260.r63">[63]</xref> Aqueous humor drains continuously through the pupil, then via the trabecular meshwork anterior to the scleral spur and iris insertion, into Schlemm canal, and finally into the episcleral venous system, larger orbital venous system, and systemic venous circulation. The trabecular meshwork consists of multiple layers of connective tissue and the endothelium of Schlemm canal, forming the primary drainage pathway for aqueous humor.<xref ref-type="bibr" rid="article-22260.r64">[64]</xref>&#x000a0;</p>
        <p>The conventional outflow pathway regulates fluid drainage from the eye in a pressure-dependent manner, acting as a one-way valve for aqueous humor drainage. In contrast, the uveoscleral outflow pathway allows pressure-independent passage of aqueous humor through the ciliary muscle and iris root into the supraciliary and suprachoroidal space.<xref ref-type="bibr" rid="article-22260.r65">[65]</xref> This&#x000a0;pathway is believed to experience reduced outflow with age. Over time, there is a decline in aqueous humor drainage through the trabecular meshwork, while the production of aqueous humor by the ciliary body decreases slightly. This imbalance between outflow and aqueous production leads to elevated average IOP and larger diurnal fluctuations in IOP, which are common features in patients with glaucoma.<xref ref-type="bibr" rid="article-22260.r66">[66]</xref>&#x000a0;</p>
        <p>Prolonged elevation of IOP leads&#x000a0;to the death and atrophy of nerve fibers, resulting in a "cupped" or curved appearance of the optic nerve head observed during fundoscopy. <xref ref-type="bibr" rid="article-22260.r67">[67]</xref>&#x000a0;The&#x000a0;normal range of IOP is approximately 16&#x000b1;3 mmHg, with values typically falling between 12&#x000a0;and&#x000a0;21 mmHg.<xref ref-type="bibr" rid="article-22260.r68">[68]</xref>&#x000a0;However, IOP fluctuates throughout the day due to various factors including heart rate, respiration, exercise, hydration status, systemic medications, time of day, alcohol intake, patient posture, and use of topical medications.</p>
        <p>Elevated pressure readings during screening, surpassing 21 mmHg, indicate pressures beyond normal physiological levels and raise concerns about potential future damage to the optic nerve due to glaucoma. However, it is challenging to determine if patients experience transient spikes in pressure during the day, leading to damage that remains undetected during screening. Consequently, elevated screening pressure serves only as a risk factor for developing glaucoma and is not sufficient for a glaucoma diagnosis. Continuous monitoring of IOP throughout the day (diurnal pressure monitoring) may aid in identifying individuals at risk in this patient population.<xref ref-type="bibr" rid="article-22260.r69">[69]</xref></p>
        <p>Patients diagnosed with normal-tension glaucoma often exhibit systemic vascular conditions such as the Raynaud phenomenon, migraines, sleep apnea, carotid artery disease, and significant nocturnal blood pressure fluctuations.<xref ref-type="bibr" rid="article-22260.r70">[70]</xref><xref ref-type="bibr" rid="article-22260.r71">[71]</xref>&#x000a0;In acute angle-closure glaucoma, the trabecular meshwork drainage pathway becomes obstructed due to the iris being pushed forward from pressure, such as an anteriorly displaced lens, or by fibrous tissue pulling the iris forward. The most common cause is a pupillary block, where the iris dilates to a mid-position, bows anteriorly upon contact with the lens, and obstructs the trabecular meshwork, thereby impeding aqueous outflow. Secondary glaucoma, as mentioned earlier, can arise from various causes such as surgery or neovascularization, leading to blockage of the outflow tracts and subsequent elevation of IOP, potentially resulting in glaucomatous optic nerve damage if left untreated.</p>
      </sec>
      <sec id="article-22260.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Many patients with glaucoma, especially early in the disease, are unaware they have this condition until it is detected during a routine eye examination. Numerous meta-analyses and systematic reviews have indicated that the prevalence of undetected glaucoma in adults exceeds 50% globally, with higher rates observed in Asia and Africa.<xref ref-type="bibr" rid="article-22260.r72">[72]</xref> Individuals typically experience a gradual loss of peripheral vision while retaining central vision until the disease progresses significantly. This can manifest as a classic arcuate pattern on Humphrey visual field testing. During a comprehensive eye examination, optic nerves may exhibit a focally notched neural retinal rim or diffuse cup enlargement, a reduction in peripheral vision detected through visual field testing, and, although not necessary for diagnosis, an elevated IOP reading on tonometry. Usually, changes are observed bilaterally but may progress asymmetrically, leading to an asymmetric optic nerve cup. A cup-to-disc ratio greater than 0.5 is often associated with glaucoma, with initial loss typically observed in the inferotemporal and superotemporal poles of the optic disc (see&#x000a0;<bold>Image. </bold>Optic Nerve Cup-to-Disc Ratio of 0.75).<xref ref-type="bibr" rid="article-22260.r73">[73]</xref></p>
        <p>Patients with normal-tension glaucoma will typically be asymptomatic and have an IOP of less than 21 mmHg, making it challenging to detect and often leading to underdiagnosis due to the normal IOP values. Slit-lamp examination reveals changes in the optic disc, such as an increased cup-to-disc ratio, along with possible disc hemorrhage in the nerve fiber layer.<xref ref-type="bibr" rid="article-22260.r74">[74]</xref> Patients may also have a medical history that includes vasospasm, coagulopathies, nocturnal hypotension, autoimmune diseases, vascular diseases, thyroid dysfunction, or sleep apnea.</p>
        <p>In acute angle-closure glaucoma, patients usually experience sudden severe ocular pain, redness, blurry vision or decreased visual acuity, headache, nausea, and vomiting, as well as may report seeing halos of light. On examination, patients have an unresponsive mid-dilated pupil and a firm feeling of eyeball upon palpation. These attacks are often triggered by pupillary dilation from weak mydriatic or dilating drops. IOP is typically significantly elevated and ranges from 30 to 50 mmHg. Predisposing risk factors for acute angle-closure glaucoma include elevated hypermetropia, an angle between the iris and the cornea around 20&#x000b0; or less observed during gonioscopy, and/or an anterior chamber depth of less than 2.5 mm.<xref ref-type="bibr" rid="article-22260.r75">[75]</xref>&#x000a0;Patients with these reports should&#x000a0;be advised to avoid dilating medications to reduce their risk of experiencing an acute attack. On slit-lamp examination, signs such as a large optic cup with narrowing of the neuroretinal rim and splinter hemorrhages may also be present.<xref ref-type="bibr" rid="article-22260.r76">[76]</xref>&#x000a0;</p>
        <p>Patients with secondary glaucoma typically have a history of recent ophthalmic procedures, trauma, or underlying health conditions causing neovascularization, such as diabetic retinopathy or previous retinal vascular occlusions. Patients may sometimes not recall a specific precipitating factor, but subtle clinical examination findings can point to the cause of elevated IOP. Examination findings may include exfoliative material on the anterior lens capsule, pigment deposition on the corneal endothelial cells, flare in the anterior chamber indicative of uveitis, abnormal blood vessels on the iris, or signs of trauma, depending on the underlying etiology.</p>
      </sec>
      <sec id="article-22260.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Assessment includes a fundoscopic examination, visual field testing, tonometry, optical coherence tomography (OCT), and gonioscopy. Of these, IOP is the greatest risk factor, thereby making tonometry of utmost importance.<xref ref-type="bibr" rid="article-22260.r77">[77]</xref>&#x000a0;Goldmann applanation tonometry is the gold standard for patients with risk factors, elevated IOP, and glaucoma, although several other types of tonometers are available.<xref ref-type="bibr" rid="article-22260.r78">[78]</xref><xref ref-type="bibr" rid="article-22260.r79">[79]</xref><xref ref-type="bibr" rid="article-22260.r80">[80]</xref> Alternative tonometers can be considered when Goldmann applanation tonometry is impractical, including&#x000a0;bedridden patients, noncollaborative individuals, children, or those allergic to anesthetic drops.<xref ref-type="bibr" rid="article-22260.r81">[81]</xref><xref ref-type="bibr" rid="article-22260.r82">[82]</xref></p>
        <p>Additional helpful tests in glaucoma evaluation include assessing visual acuity to determine any impact on vision, pachymetry to measure corneal thickness, and retinal scans to monitor progressive changes in the retinal nerve fiber layer. Regular visual field testing using full-threshold strategies is crucial for individuals with risk factors, ocular hypertension, and those undergoing glaucoma treatment.<xref ref-type="bibr" rid="article-22260.r83">[83]</xref><xref ref-type="bibr" rid="article-22260.r84">[84]</xref><xref ref-type="bibr" rid="article-22260.r85">[85]</xref> OCT is valuable for monitoring morphological changes in the optic nerve and retinal nerve fiber layer, especially in patients with ocular hypertension and early-to-moderate glaucoma.<xref ref-type="bibr" rid="article-22260.r86">[86]</xref></p>
        <p>Glaucoma diagnosis relies on identifying progressive optic neuropathy and/or visual field defects, often in conjunction with elevated IOP. Ocular hypertension is diagnosed in individuals with IOP levels exceeding 21 mmHg without signs of glaucomatous optic neuropathy or functional visual field defects. Research indicates that around 20% of people with ocular hypertension may progress to glaucoma, highlighting the importance of regular testing, tonometry, and comprehensive eye examinations to initiate appropriate treatment aimed at reducing IOP in the presence of initial glaucomatous damage.<xref ref-type="bibr" rid="article-22260.r87">[87]</xref>&#x000a0;</p>
        <p>A single gold standard test does not exist for diagnosing glaucoma. Typically, glaucoma is diagnosed during routine eye examinations, as the disease is often asymptomatic without noticeable vision loss. Clinicians rely on recognizing the characteristic appearance of the optic nerve, assessing risk factors, and interpreting ancillary test results to establish an accurate diagnosis and stage of glaucoma.<xref ref-type="bibr" rid="article-22260.r88">[88]</xref>&#x000a0;Currently, the American Academy of Ophthalmology recommends routine comprehensive eye examinations for individuals with glaucoma risk factors, with the examination frequency tailored to factors such as age, race, family history, and specific risk factors.<xref ref-type="bibr" rid="article-22260.r89">[89]</xref></p>
      </sec>
      <sec id="article-22260.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Managing glaucoma involves personalized strategies based on the type and severity of the condition. Available treatments cannot reverse vision loss; they aim to lower IOP, a key risk factor, to prevent further damage and vision loss. Therapeutic options such as eye drops, laser procedures, and surgeries are focused on reducing IOP. Monitoring disease progression involves using tools like tonometry, visual field tests, OCT, and vision loss mapping.</p>
        <p>Open-angle glaucoma is typically managed initially with medications aimed at reducing eye pressure. Common medication classes include prostaglandin analogs, &#x003b2;-blockers, carbonic anhydrase inhibitors, &#x003b1;-2 agonists, miotic agents, and more recently, Rho-kinase inhibitors and nitric oxide-donating medications.<xref ref-type="bibr" rid="article-22260.r90">[90]</xref><xref ref-type="bibr" rid="article-22260.r91">[91]</xref> Laser trabeculoplasty, such as argon laser trabeculoplasty, selective laser trabeculoplasty, and multipulse laser trabeculoplasty, may also be considered in certain cases. However, the benefits of lowering IOP with laser trabeculoplasty often last several months, and retreatments are commonly necessary.<xref ref-type="bibr" rid="article-22260.r92">[92]</xref>&#x000a0;</p>
        <p>If medical and/or laser management is unsuccessful, procedures such as trabeculectomy, deep sclerectomy, canaloplasty, insertion of a drainage valve/tube shunt, and laser treatment to the ciliary body to reduce aqueous production can help achieve better control of IOP.<xref ref-type="bibr" rid="article-22260.r93">[93]</xref><xref ref-type="bibr" rid="article-22260.r94">[94]</xref><xref ref-type="bibr" rid="article-22260.r95">[95]</xref>&#x000a0;Minimally&#x000a0;invasive glaucoma surgery (MIGS) is an emerging option for individuals with mild-to-moderate glaucoma.<xref ref-type="bibr" rid="article-22260.r96">[96]</xref> Compared to traditional trabeculectomy and tube shunts, MIGS offers a more favorable safety profile, quicker recovery time, and effective reduction of IOP to the mid-high teens. Studies also indicate that MIGS placement can decrease the number of pressure-lowering medications needed to maintain target IOP levels.<xref ref-type="bibr" rid="article-22260.r97">[97]</xref></p>
        <p>Normal-tension glaucoma can be managed with medications to reduce IOP and address any underlying medical conditions. Treatment options include prostaglandin analogs, &#x003b1;-2 agonists, carbonic anhydrase inhibitors, and miotics. The use of &#x003b2;-blockers is debated due to concerns about reduced optic nerve head perfusion, particularly regarding the potential exacerbation of the early morning nadir in blood pressure. If medical therapy proves ineffective, laser trabeculoplasty or filtration surgery may be necessary, especially in cases of progressive vision loss. The collaborative normal-tension glaucoma study demonstrated that patients with this condition can slow or stabilize their field loss after achieving a 30% reduction in IOP.<xref ref-type="bibr" rid="article-22260.r98">[98]</xref></p>
        <p>Angle-closure glaucoma is considered a medical emergency due to the potential for elevated pressures leading to glaucomatous optic nerve damage, ischemic nerve damage, or retinal vascular occlusion.&#x000a0;Patients can take medications to reduce eye pressure as quickly as possible but usually require a laser procedure called laser peripheral iridotomy. This procedure involves creating a small hole in the iris to alleviate pupillary blockage. By equalizing the pressure gradient between the posterior and anterior chambers, laser iridotomy resolves the iris bombe and opens up the drainage angle in the anterior chamber, relieving the condition. The peripheral iris can be flattened with laser iridoplasty and, less commonly, with laser pupilloplasty.</p>
        <p>A decrease in IOP does not always indicate that the angle has reopened. Ischemic damage to the ciliary body during an attack can reduce aqueous humor production for several weeks. Therefore, it is crucial to perform a follow-up gonioscopy to confirm angle patency. This evaluation also helps assess the percentage of the angle with peripheral anterior synechia from acute or prior subacute attacks. After resolving the acute crisis, patients are at a high risk of experiencing an attack in the contralateral eye. Therefore, they should undergo gonioscopy to assess the angle and consider prophylactic iridotomy in the other eye if the angle is narrow.<xref ref-type="bibr" rid="article-22260.r99">[99]</xref> Treatment for secondary glaucoma should focus on addressing the underlying cause along with the possible inclusion of medications to reduce IOP.<xref ref-type="bibr" rid="article-22260.r100">[100]</xref></p>
      </sec>
      <sec id="article-22260.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>When diagnosing POAG, it is crucial to rule out other conditions that can cause optic neuropathy. Differential diagnoses to consider include previous ischemic optic neuropathy, optic atrophy, and compressive non-glaucomatous optic neuropathy, as they can exhibit similar visual field loss patterns and, in some cases, lead to "pseudo-cupping" of the optic nerve.<xref ref-type="bibr" rid="article-22260.r101">[101]</xref> If elevated IOP or characteristic glaucomatous optic nerve changes are observed, performing a gonioscopy is essential to assess the anterior chamber's status (open, narrow, or closed). Moreover, clinicians should be vigilant for subtle signs of various secondary glaucomas, review the patient's medication history for potential idiosyncratic drug reactions or steroid responses, and gather a comprehensive history of prior ocular trauma and surgeries.</p>
        <p>With an acute presentation resembling acute angle-closure glaucoma, clinicians should also consider other potential diagnoses such as iritis, traumatic hyphema, conjunctivitis, episcleritis, migraine, cluster headache, subconjunctival hemorrhage, corneal abrasion, endophthalmitis, orbital compartment syndrome, corneal ulcer, periorbital infections, and infectious keratitis. A thorough history-taking and detailed slit-lamp examination are crucial for narrowing down the differentials and arranging appropriate examinations or referrals as needed.<xref ref-type="bibr" rid="article-22260.r102">[102]</xref><xref ref-type="bibr" rid="article-22260.r103">[103]</xref><xref ref-type="bibr" rid="article-22260.r104">[104]</xref></p>
      </sec>
      <sec id="article-22260.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Glaucoma is not a benign disorder, and if left untreated, it can lead to permanent vision loss. The higher the pressure and the duration of elevated IOP, the greater the risk of damaging the optic nerve. Timely diagnosis plays a critical role in mitigating glaucomatous damage, and early intervention is crucial in preventing and slowing down vision loss progression. Effective treatment, especially in maintaining low IOP levels, can often lead to positive outcomes, preserving visual field integrity and halting disease advancement.</p>
      </sec>
      <sec id="article-22260.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of glaucoma include visual field loss and can lead to eventual complete blindness, with a progression to no light perception vision in the affected eye.<xref ref-type="bibr" rid="article-22260.r105">[105]</xref></p>
      </sec>
      <sec id="article-22260.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Standard screening during a complete eye examination includes checking the IOP of both eyes. Alongside tonometry, periodic eye examinations should encompass a thorough anterior segment evaluation and a fundoscopic exam, with special attention to the optic nerve. These initial screening tests are crucial for identifying glaucoma suspects early in the disease course. High-risk glaucoma suspects require further diagnostic testing such as visual field examination, OCT, pachymetry, and gonioscopy to confirm the diagnosis.</p>
        <p>Patients should be educated about the causes, risk factors, and treatment for glaucoma. They should understand that most cases of glaucoma result in slow, progressive vision loss that often goes unnoticed until a significant portion of the visual field is affected. Therefore, regular eye exams are highly recommended to identify high-risk patients promptly and prevent irreversible vision loss.</p>
      </sec>
      <sec id="article-22260.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Glaucoma represents a chronic and severe condition that may lead to irreversible vision loss if detected late in its progression. Effective management of the condition involves an interprofessional team focused on addressing patients' visual health concerns. A crucial aspect of treatment lies in patient education. Pharmacists should emphasize the importance of medication compliance and the necessity of regular follow-ups with the eye specialist. Ophthalmic technicians must collaborate closely with clinicians to oversee scheduled visual field and OCT assessments. Ophthalmic nurses are responsible for monitoring IOP and communicating these findings promptly to the ophthalmologist for further evaluation and management. This collaborative approach ensures comprehensive care and better outcomes for patients with glaucoma.</p>
        <p>Regular eye appointments and compliance with medication are vital to&#x000a0;lessening disease progression in glaucoma patients. Given its hereditary nature, educating family members about the increased risk of developing glaucoma is important, prompting them to undergo regular screenings for early detection.&#x000a0;Notably, healthcare team members must consult&#x000a0;the ophthalmologist before making any changes to medication dosage or frequency.&#x000a0;Effective communication among healthcare providers is essential to reduce the morbidity associated with glaucoma.<xref ref-type="bibr" rid="article-22260.r106">[106]</xref></p>
      </sec>
      <sec id="article-22260.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22260&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22260">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/glaucoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22260">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22260/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22260">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22260.s15">
        <fig id="article-22260.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Glaucomatous Optic Nerve Head Showing Inferotemporal Retinal Nerve Fiber Layer Defect. Increased intraocular pressure&#x000a0;can result in reduced blood supply to the optic nerve fibers, resulting in subtle ischemic injury. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="poag" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22260.s16">
        <fig id="article-22260.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Left Eye Glaucomatous Visual Field Changes.&#x000a0;This image displays the results of a visual field test indicating characteristic changes associated with glaucoma in the left eye, as observed on perimetry. Contributed by S Shah, MBBS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1628623000792" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22260.s17">
        <fig id="article-22260.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Optic Nerve Cup-to-Disc Ratio of 0.75.&#x000a0;A cup-to-disc ratio greater than 0.5 is often associated with glaucoma, and initial loss is typically observed in the inferotemporal and superotemporal poles of the optic disc. Contributed by AS Huang, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Screen__Shot__2021-10-04__at__5.06.26__PM" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22260.s18">
        <fig id="article-22260.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Hypermature Morgagnian Cataract.&#x000a0;&#x000a0;This image captures the outcome of treatment for an older male patient who initially presented with severe corneal edema, congestion, and elevated intraocular pressure. Following the administration of antiglaucoma medications and topical steroids, a remarkable reduction in corneal edema was observed, exposing a hypermature Morgagnian cataract. Sridhar U.&#x000a0;<italic toggle="yes">Cornea Illustrated: A Guide to Clinical Diagnosis.&#x000a0;</italic>Kolkata, West Bengal, India: New Central Book Agency; 2017.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fig__5c" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22260.s19">
        <fig id="article-22260.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Advanced Glaucomatous Damage to the Optic Nerve.&#x000a0;This image illustrates the severe and advanced glaucomatous damage to the optic nerve observed in a patient with high myopia. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Glaucoma__in__myopia" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22260.s20">
        <title>References</title>
        <ref id="article-22260.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ezinne</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Shittu</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ekemiri</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Kwarteng</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tagoh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogbonna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mashige</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Visual Impairment and Blindness among Patients at Nigeria Army Eye Centre, Bonny Cantonment Lagos, Nigeria.</article-title>
            <source>Healthcare (Basel)</source>
            <year>2022</year>
            <month>Nov</month>
            <day>18</day>
            <volume>10</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">36421637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mahabadi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Open Angle Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">28722917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagner</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Dorairaj</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Updates on the Diagnosis and Management of Glaucoma.</article-title>
            <source>Mayo Clin Proc Innov Qual Outcomes</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>618</fpage>
            <page-range>618-635</page-range>
            <pub-id pub-id-type="pmid">36405987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of glaucoma: what's new?</article-title>
            <source>Can J Ophthalmol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>223</fpage>
            <page-range>223-6</page-range>
            <pub-id pub-id-type="pmid">22687296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallo Afflitto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aiello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cesareo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nucci</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Primary Open Angle Glaucoma Prevalence in Europe: A Systematic Review and Meta-Analysis.</article-title>
            <source>J Glaucoma</source>
            <year>2022</year>
            <month>Oct</month>
            <day>01</day>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>783</fpage>
            <page-range>783-788</page-range>
            <pub-id pub-id-type="pmid">35980843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bhushan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Assessment of optic disk by disk damage likelihood scale staging using slit-lamp biomicroscopy and optical coherence tomography in diagnosing primary open-angle glaucoma.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>70</volume>
            <issue>12</issue>
            <fpage>4152</fpage>
            <page-range>4152-4157</page-range>
            <pub-id pub-id-type="pmid">36453304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Bron</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ritch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panda-Jonas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Nov</month>
            <day>11</day>
            <volume>390</volume>
            <issue>10108</issue>
            <fpage>2183</fpage>
            <page-range>2183-2193</page-range>
            <pub-id pub-id-type="pmid">28577860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kavitha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Odayappan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinical and demographic profile of patients less than 40 years of age presenting to glaucoma services at a tertiary care eye hospital in South India.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>70</volume>
            <issue>12</issue>
            <fpage>4186</fpage>
            <page-range>4186-4192</page-range>
            <pub-id pub-id-type="pmid">36453311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Khazaeni</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khazaeni</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <chapter-title>Acute Angle-Closure Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>11</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">28613607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Luben</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Khawaja</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Association, Risk, and Causation-Examining the Role of Systemic Medications in the Onset of Acute Angle-Closure Episodes.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2022</year>
            <month>Nov</month>
            <day>01</day>
            <volume>140</volume>
            <issue>11</issue>
            <fpage>1064</fpage>
            <page-range>1064-1065</page-range>
            <pub-id pub-id-type="pmid">36136324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>TYB</given-names>
              </name>
            </person-group>
            <article-title>Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2022</year>
            <volume>16</volume>
            <fpage>2385</fpage>
            <page-range>2385-2390</page-range>
            <pub-id pub-id-type="pmid">35936971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gosling</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <chapter-title>Normal Tension Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>12</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">35015402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bailey</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Loomis</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Allingham</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Gharahkhani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khor</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Burdon</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Aschard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chasman</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Igo</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Hysi</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Glastonbury</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Ashley-Koch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brilliant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Budenz</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Buil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Christen</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Curhan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Vivo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fingert</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gaasterland</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gaasterland</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hewitt</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Khawaja</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lichter</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>McGuffin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moroi</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Perera</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Pepper</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Realini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ridker</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Rimm</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ritch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schuman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sit</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Tamimi</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Topouzis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Viswanathan</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Vollrath</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Weisschuh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wissinger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wollstein</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Yaspan</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Zack</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Study</surname>
                <given-names>EN</given-names>
              </name>
              <collab>ANZRAG Consortium</collab>
              <name>
                <surname>Weinreb</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Pericak-Vance</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Small</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hammond</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Vithana</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>MacGregor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kraft</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hauser</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Pasquale</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Haines</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wiggs</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma.</article-title>
            <source>Nat Genet</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-94</page-range>
            <pub-id pub-id-type="pmid">26752265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research.</article-title>
            <source>Eur J Med Chem</source>
            <year>2021</year>
            <month>Dec</month>
            <day>15</day>
            <volume>226</volume>
            <fpage>113842</fpage>
            <pub-id pub-id-type="pmid">34536672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buffault</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Labb&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brignole-Baudouin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baudouin</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The trabecular meshwork: Structure, function and clinical implications. A review of the literature.</article-title>
            <source>J Fr Ophtalmol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>7</issue>
            <fpage>e217</fpage>
            <page-range>e217-e230</page-range>
            <pub-id pub-id-type="pmid">32561029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>BQ</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies.</article-title>
            <source>Neural Regen Res</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-93</page-range>
            <pub-id pub-id-type="pmid">35799514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kaur</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Primary Congenital Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">34662067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeung</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Kumar-Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Walton</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Infantile Aphakic Glaucoma: A Proposed Mechanism.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>2022</year>
            <season>Jul-Aug</season>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>236</fpage>
            <page-range>236-242</page-range>
            <pub-id pub-id-type="pmid">34928772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r19">
          <label>19</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Jafer Chardoub</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Juvenile Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">32965934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turalba</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Clinical and genetic characteristics of primary juvenile-onset open-angle glaucoma (JOAG).</article-title>
            <source>Semin Ophthalmol</source>
            <year>2008</year>
            <season>Jan-Feb</season>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-25</page-range>
            <pub-id pub-id-type="pmid">18214788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drance</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Schulzer</surname>
                <given-names>M</given-names>
              </name>
              <collab>Collaborative Normal-Tension Glaucoma Study Group</collab>
            </person-group>
            <article-title>Risk factors for progression of visual field abnormalities in normal-tension glaucoma.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>131</volume>
            <issue>6</issue>
            <fpage>699</fpage>
            <page-range>699-708</page-range>
            <pub-id pub-id-type="pmid">11384564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terelak-Borys</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Czechowicz-Janicka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Investigation into the vasospastic mechanisms in the pathogenesis of glaucomatous neuropathy.</article-title>
            <source>Klin Oczna</source>
            <year>2011</year>
            <volume>113</volume>
            <issue>7-9</issue>
            <fpage>201</fpage>
            <page-range>201-8</page-range>
            <pub-id pub-id-type="pmid">22256559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reinehr</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guntermann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Theile</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Benning</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Grotegut</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kuehn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Serschnitzki</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Joachim</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Proteomic Analysis of Retinal Tissue in an S100B Autoimmune Glaucoma Model.</article-title>
            <source>Biology (Basel)</source>
            <year>2021</year>
            <month>Dec</month>
            <day>23</day>
            <volume>11</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">35053014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nowrouzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benitez-Del-Castillo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kafi-Abasabadi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rodriguez-Calzadilla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Diaz-Ramos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodriguez-Suarez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mota-Chozas</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Peripheral vascular disease - a new vascular disease associated with normal tension glaucoma: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2020</year>
            <month>Nov</month>
            <day>19</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>224</fpage>
            <pub-id pub-id-type="pmid">33208187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sung</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Heo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the Structure-Function Relationship Between Advanced Primary Open Angle Glaucoma and Normal Tension Glaucoma.</article-title>
            <source>J Glaucoma</source>
            <year>2022</year>
            <month>Jul</month>
            <day>01</day>
            <volume>31</volume>
            <issue>7</issue>
            <fpage>574</fpage>
            <page-range>574-583</page-range>
            <pub-id pub-id-type="pmid">35583511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r26">
          <label>26</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dave</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <chapter-title>Chronic Closed Angle Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>1</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32644524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sener</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Evereklioglu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Horozoglu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sener</surname>
                <given-names>ABG</given-names>
              </name>
            </person-group>
            <article-title>Optic nerve head vessel density using OCTA in patients with primary angle closure disease: A systematic review and network meta-analysis.</article-title>
            <source>Photodiagnosis Photodyn Ther</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>41</volume>
            <fpage>103209</fpage>
            <pub-id pub-id-type="pmid">36493693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samokhvalov</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Sorokin</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Marchenko</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Pashentsev</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>[Anatomical and morphometric features of anterior eye segment structures in hyperopia and the risk of developing primary angle-closure glaucoma].</article-title>
            <source>Vestn Oftalmol</source>
            <year>2022</year>
            <volume>138</volume>
            <issue>5</issue>
            <fpage>22</fpage>
            <page-range>22-28</page-range>
            <pub-id pub-id-type="pmid">36288414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cai</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Babenko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Numerical study of aqueous humor flow and iris deformation with pupillary block and the efficacy of laser peripheral iridotomy.</article-title>
            <source>Clin Biomech (Bristol, Avon)</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>92</volume>
            <fpage>105579</fpage>
            <pub-id pub-id-type="pmid">35085976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Douglas</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Drance</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Schulzer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The visual field and nerve head in angle-closure glaucoma. A comparison of the effects of acute and chronic angle closure.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1975</year>
            <month>Jun</month>
            <volume>93</volume>
            <issue>6</issue>
            <fpage>409</fpage>
            <page-range>409-11</page-range>
            <pub-id pub-id-type="pmid">1131080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Izquierdo</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Traboulsi</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Enger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maumenee</surname>
                <given-names>IH</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma in the Marfan syndrome.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1992</year>
            <volume>90</volume>
            <fpage>111</fpage>
            <page-range>111-7; discussion 118-22</page-range>
            <pub-id pub-id-type="pmid">1494814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kondo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Isono</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A case of angle-closure glaucoma caused by spontaneous lens dislocation.</article-title>
            <source>Clin Case Rep</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>e6670</fpage>
            <pub-id pub-id-type="pmid">36483875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r33">
          <label>33</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Shah</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <chapter-title>Lens-Induced Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>9</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">34662038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kale</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Isik</surname>
                <given-names>DU</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Hekimoglu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Bas</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Demirel</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Neonatal Marfan syndrome with angle-closure glaucoma, tricuspid and mitral insufficiency.</article-title>
            <source>Genet Couns</source>
            <year>2015</year>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>95</fpage>
            <page-range>95-8</page-range>
            <pub-id pub-id-type="pmid">26043516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alshomar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Alsirhy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mirza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Osman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alobaidan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Osman</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Plateau Iris Syndrome among Patients Presenting with Primary Angle Closure and Primary Angle-Closure Glaucoma in a Tertiary Eye Care Hospital.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2021</year>
            <season>Oct-Dec</season>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>221</fpage>
            <page-range>221-225</page-range>
            <pub-id pub-id-type="pmid">35719280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiuchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kanamoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Double hump sign in indentation gonioscopy is correlated with presence of plateau iris configuration regardless of patent iridotomy.</article-title>
            <source>J Glaucoma</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-4</page-range>
            <pub-id pub-id-type="pmid">19225356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laganowski</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kerr Muir</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Hitchings</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma and the iridocorneal endothelial syndrome.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>346</fpage>
            <page-range>346-50</page-range>
            <pub-id pub-id-type="pmid">1543451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'cruz</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>'Progressive peripheral anterior synechiae in iridocorneoendothelial syndrome- a crawling disaster'.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2023</year>
            <month>May</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>NP40</fpage>
            <page-range>NP40-NP44</page-range>
            <pub-id pub-id-type="pmid">34964381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sivak-Callcott</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>O'Day</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma.</article-title>
            <source>Ophthalmology</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>108</volume>
            <issue>10</issue>
            <fpage>1767</fpage>
            <page-range>1767-76; quiz1777, 1800</page-range>
            <pub-id pub-id-type="pmid">11581047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r40">
          <label>40</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mishra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <chapter-title>Neovascular Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>11</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">35015418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perez</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Angel-closure glaucoma following scleral buckling operations.</article-title>
            <source>Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol</source>
            <year>1976</year>
            <season>Mar-Apr</season>
            <volume>81</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-52</page-range>
            <pub-id pub-id-type="pmid">936397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aminlari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>East</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Quillen</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Topiramate induced acute angle closure glaucoma.</article-title>
            <source>Open Ophthalmol J</source>
            <year>2008</year>
            <month>Mar</month>
            <day>28</day>
            <volume>2</volume>
            <fpage>46</fpage>
            <page-range>46-7</page-range>
            <pub-id pub-id-type="pmid">19478906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shivkumar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gadiwan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rout</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haroon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramakrishnan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Visual outcomes and complications of manual small-incision cataract surgery in patients with pseudoexfoliation.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>70</volume>
            <issue>11</issue>
            <fpage>3912</fpage>
            <page-range>3912-3917</page-range>
            <pub-id pub-id-type="pmid">36308126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collao</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>MZ</given-names>
              </name>
              <name>
                <surname>Abdelrahman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-de-la-Casa</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vidal-Villegas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Burgos-Blasco</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Analyses of pseudoexfoliation aqueous humor lipidome.</article-title>
            <source>Mol Omics</source>
            <year>2022</year>
            <month>Jun</month>
            <day>13</day>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>387</fpage>
            <page-range>387-396</page-range>
            <pub-id pub-id-type="pmid">35485348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r45">
          <label>45</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Tuteja</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <chapter-title>Pseudoexfoliation Syndrome and Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">34662036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r46">
          <label>46</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Pigment Dispersion Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">35593834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plateroti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plateroti</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Abdolrahimzadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scuderi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma: A Review of the Literature with Updates on Surgical Management.</article-title>
            <source>J Ophthalmol</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>370371</fpage>
            <pub-id pub-id-type="pmid">26605078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pigment dispersion syndrome: A brief overview.</article-title>
            <source>J Clin Transl Res</source>
            <year>2022</year>
            <month>Oct</month>
            <day>31</day>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>344</fpage>
            <page-range>344-350</page-range>
            <pub-id pub-id-type="pmid">36518550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r49">
          <label>49</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Pigment Dispersion Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35593820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r50">
          <label>50</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Feroze</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khazaeni</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <chapter-title>Steroid-Induced Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">28613653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roll</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Benedikt</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>[Electronmicroscopic studies of the trabecular meshwork in corticosteroid glaucoma].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>1979</year>
            <month>Mar</month>
            <volume>174</volume>
            <issue>3</issue>
            <fpage>421</fpage>
            <page-range>421-8</page-range>
            <pub-id pub-id-type="pmid">480814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khurana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alam</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Balekudaru</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vijaya</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Madhuri</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Halbe</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Noronha</surname>
                <given-names>VO</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Intraocular Pressure in the Eyes of Patients With Carotid-Cavernous Fistulas: Profile, Intereye Asymmetry, and Treatment Outcomes.</article-title>
            <source>J Glaucoma</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>1074</fpage>
            <page-range>1074-1078</page-range>
            <pub-id pub-id-type="pmid">31658226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calafiore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Perdicchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scuderi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Contestabile</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Abdolrahimzadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Recupero</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma Management in Carotid Cavernous Fistula.</article-title>
            <source>Case Rep Ophthalmol</source>
            <year>2016</year>
            <season>May-Aug</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>296</fpage>
            <page-range>296-302</page-range>
            <pub-id pub-id-type="pmid">27462258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greslechner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Helbig</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Spiegel</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].</article-title>
            <source>Ophthalmologe</source>
            <year>2022</year>
            <month>May</month>
            <volume>119</volume>
            <issue>5</issue>
            <fpage>533</fpage>
            <page-range>533-546</page-range>
            <pub-id pub-id-type="pmid">35471612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r55">
          <label>55</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Uveitis Glaucoma Hyphema Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>29</day>
            <pub-id pub-id-type="pmid">35593837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r56">
          <label>56</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Okonkwo</surname>
                <given-names>ON</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Posner-Schlossman Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">35015437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choong</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Irfan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Menage</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Acute angle closure glaucoma: an evaluation of a protocol for acute treatment.</article-title>
            <source>Eye (Lond)</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>13 ( Pt 5)</volume>
            <fpage>613</fpage>
            <page-range>613-6</page-range>
            <pub-id pub-id-type="pmid">10696311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>POSNER</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>SCHLOSSMAN</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Further observations on the syndrome of glaucomatocyclitic crises.</article-title>
            <source>Trans Am Acad Ophthalmol Otolaryngol</source>
            <year>1953</year>
            <season>Jul-Aug</season>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>531</fpage>
            <page-range>531-6</page-range>
            <pub-id pub-id-type="pmid">13090248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allison</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alabi</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future.</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Nov</month>
            <day>24</day>
            <volume>12</volume>
            <issue>11</issue>
            <fpage>e11686</fpage>
            <pub-id pub-id-type="pmid">33391921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imrie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tatham</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma: the patient's perspective.</article-title>
            <source>Br J Gen Pract</source>
            <year>2016</year>
            <month>May</month>
            <volume>66</volume>
            <issue>646</issue>
            <fpage>e371</fpage>
            <page-range>e371-3</page-range>
            <pub-id pub-id-type="pmid">27127293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourne</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Flaxman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Keeffe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leasher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Naidoo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pesudovs</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Resnikoff</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>HR</given-names>
              </name>
              <collab>Vision Loss Expert Group</collab>
            </person-group>
            <article-title>Causes of vision loss worldwide, 1990-2010: a systematic analysis.</article-title>
            <source>Lancet Glob Health</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>1</volume>
            <issue>6</issue>
            <fpage>e339</fpage>
            <page-range>e339-49</page-range>
            <pub-id pub-id-type="pmid">25104599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>DYL</given-names>
              </name>
              <name>
                <surname>Tham</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Normal-tension glaucoma: Current concepts and approaches-A review.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-259</page-range>
            <pub-id pub-id-type="pmid">35040248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heijl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bengtsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hyman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Leske</surname>
                <given-names>MC</given-names>
              </name>
              <collab>Early Manifest Glaucoma Trial Group</collab>
            </person-group>
            <article-title>Natural history of open-angle glaucoma.</article-title>
            <source>Ophthalmology</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>116</volume>
            <issue>12</issue>
            <fpage>2271</fpage>
            <page-range>2271-6</page-range>
            <pub-id pub-id-type="pmid">19854514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reina-Torres</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baptiste</surname>
                <given-names>TMG</given-names>
              </name>
              <name>
                <surname>Overby</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Segmental outflow dynamics in the trabecular meshwork of living mice.</article-title>
            <source>Exp Eye Res</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>225</volume>
            <fpage>109285</fpage>
            <pub-id pub-id-type="pmid">36273576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pandya</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sofi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Somarajan</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nag</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Differences in outflow channels between two eyes of unilateral primary congenital glaucoma.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>99</volume>
            <issue>2</issue>
            <fpage>187</fpage>
            <page-range>187-194</page-range>
            <pub-id pub-id-type="pmid">32701215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baig</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Tham</surname>
                <given-names>CCY</given-names>
              </name>
            </person-group>
            <article-title>Association of Ultra-Short-Term Intraocular Pressure Fluctuation With Disease Progression in Primary Angle Closure Glaucoma: The CUPAL Study.</article-title>
            <source>J Glaucoma</source>
            <year>2022</year>
            <month>Nov</month>
            <day>01</day>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>874</fpage>
            <page-range>874-880</page-range>
            <pub-id pub-id-type="pmid">35980863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Omodaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kabakura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Himori</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ninomiya</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pak</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Akiba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of glaucoma patients with various risk factors.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2022</year>
            <month>Sep</month>
            <day>19</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>373</fpage>
            <pub-id pub-id-type="pmid">36123604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolvaardt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Measuring intraocular pressure.</article-title>
            <source>Community Eye Health</source>
            <year>2019</year>
            <volume>32</volume>
            <issue>107</issue>
            <fpage>56</fpage>
            <page-range>56-57</page-range>
            <pub-id pub-id-type="pmid">32123477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arora</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bali</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wadhwani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Panda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dada</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Diurnal versus office-hour intraocular pressure fluctuation in primary adult onset glaucoma.</article-title>
            <source>J Optom</source>
            <year>2015</year>
            <season>Oct-Dec</season>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>239</fpage>
            <page-range>239-43</page-range>
            <pub-id pub-id-type="pmid">26386536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levene</surname>
                <given-names>RZ</given-names>
              </name>
            </person-group>
            <article-title>Low tension glaucoma: a critical review and new material.</article-title>
            <source>Surv Ophthalmol</source>
            <year>1980</year>
            <season>May-Jun</season>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>621</fpage>
            <page-range>621-64</page-range>
            <pub-id pub-id-type="pmid">7414505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drance</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Factors involved in the production of low tension glaucoma.</article-title>
            <source>Can J Ophthalmol</source>
            <year>1974</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>399</fpage>
            <page-range>399-403</page-range>
            <pub-id pub-id-type="pmid">4423185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soh</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Betzler</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Majithia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tham</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis.</article-title>
            <source>Ophthalmology</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>128</volume>
            <issue>10</issue>
            <fpage>1393</fpage>
            <page-range>1393-1404</page-range>
            <pub-id pub-id-type="pmid">33865875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>St&#x000fc;rmer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pattern of glaucomatous neuroretinal rim loss.</article-title>
            <source>Ophthalmology</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-8</page-range>
            <pub-id pub-id-type="pmid">8433829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chuangsuwanich</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tun</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Braeu</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>ZY</given-names>
              </name>
              <name>
                <surname>Panda</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Buist</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strouthidis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Perera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nongpiur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Girard</surname>
                <given-names>MJA</given-names>
              </name>
            </person-group>
            <article-title>Differing Associations between Optic Nerve Head Strains and Visual Field Loss in Patients with Normal- and High-Tension Glaucoma.</article-title>
            <source>Ophthalmology</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>130</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-110</page-range>
            <pub-id pub-id-type="pmid">35964710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moghimi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramezani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Anterior Segment-Optical Coherence Tomography Parameters in Phacomorphic Angle Closure and Acute Angle Closure Eyes.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>13</issue>
            <fpage>7611</fpage>
            <page-range>7611-7</page-range>
            <pub-id pub-id-type="pmid">26624492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Muliyil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jacob</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>87</volume>
            <issue>4</issue>
            <fpage>450</fpage>
            <page-range>450-4</page-range>
            <pub-id pub-id-type="pmid">12642309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r77">
          <label>77</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bader</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Havens</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <chapter-title>Tonometry</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>12</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">29630277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salvetat</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>How to Measure Intraocular Pressure: An Updated Review of Various Tonometers.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>Aug</month>
            <day>27</day>
            <volume>10</volume>
            <issue>17</issue>
            <pub-id pub-id-type="pmid">34501306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salvetat</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>It Is All about Pressure.</article-title>
            <source>J Clin Med</source>
            <year>2022</year>
            <month>Jun</month>
            <day>23</day>
            <volume>11</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">35806926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r80">
          <label>80</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Applanation Tonometry</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">35881737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvetat</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tosoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Repeatability and accuracy of applanation resonance tonometry in healthy subjects and patients with glaucoma.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>92</volume>
            <issue>1</issue>
            <fpage>e66</fpage>
            <page-range>e66-73</page-range>
            <pub-id pub-id-type="pmid">23837834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvetat</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tosoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Comparisons between Pascal dynamic contour tonometry, the TonoPen, and Goldmann applanation tonometry in patients with glaucoma.</article-title>
            <source>Acta Ophthalmol Scand</source>
            <year>2007</year>
            <month>May</month>
            <volume>85</volume>
            <issue>3</issue>
            <fpage>272</fpage>
            <page-range>272-9</page-range>
            <pub-id pub-id-type="pmid">17488456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvetat</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tosoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Felletti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grasso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Corneal Deformation Parameters Provided by the Corvis-ST Pachy-Tonometer in Healthy Subjects and Glaucoma Patients.</article-title>
            <source>J Glaucoma</source>
            <year>2015</year>
            <season>Oct-Nov</season>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>568</fpage>
            <page-range>568-74</page-range>
            <pub-id pub-id-type="pmid">25318572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Miglior</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Corneal thickness and functional damage in patients with ocular hypertension.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2005</year>
            <season>Mar-Apr</season>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-201</page-range>
            <pub-id pub-id-type="pmid">15812759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvetat</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tosoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parisi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Non-conventional perimetric methods in the detection of early glaucomatous functional damage.</article-title>
            <source>Eye (Lond)</source>
            <year>2010</year>
            <month>May</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>835</fpage>
            <page-range>835-42</page-range>
            <pub-id pub-id-type="pmid">19696803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmoudinezhad</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moghimi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Proudfoot</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Brye</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yarmohammadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kamalipour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zangwill</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Weinreb</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Effect of Testing Frequency on the Time to Detect Glaucoma Progression With Optical Coherence Tomography (OCT) and OCT Angiography.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>245</volume>
            <fpage>184</fpage>
            <page-range>184-192</page-range>
            <pub-id pub-id-type="pmid">36096181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelly</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Khawaja</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Azuara-Blanco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sparrow</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Crabb</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Progression from ocular hypertension to visual field loss in the English hospital eye service.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>104</volume>
            <issue>10</issue>
            <fpage>1406</fpage>
            <page-range>1406-1411</page-range>
            <pub-id pub-id-type="pmid">32217541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>XH</given-names>
              </name>
            </person-group>
            <article-title>[The study of the correlation between age and the pathogenic factors of primary glaucoma: a review].</article-title>
            <source>Zhonghua Yan Ke Za Zhi</source>
            <year>2022</year>
            <month>Dec</month>
            <day>11</day>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>1106</fpage>
            <page-range>1106-1110</page-range>
            <pub-id pub-id-type="pmid">36480899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvetat</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tosoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
              <collab>Medscape</collab>
            </person-group>
            <article-title>Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.</article-title>
            <source>Eye (Lond)</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>784</fpage>
            <page-range>784-95</page-range>
            <pub-id pub-id-type="pmid">27174381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buffault</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brignole-Baudouin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Reboussin</surname>
                <given-names>&#x000c9;</given-names>
              </name>
              <name>
                <surname>Kessal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Labb&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>M&#x000e9;lik Parsadaniantz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baudouin</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The Dual Effect of Rho-Kinase Inhibition on Trabecular Meshwork Cells Cytoskeleton and Extracellular Matrix in an In Vitro Model of Glaucoma.</article-title>
            <source>J Clin Med</source>
            <year>2022</year>
            <month>Feb</month>
            <day>15</day>
            <volume>11</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">35207274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walters</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Kothe</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Usner</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Duquesroix</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fechtner</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Navratil</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study.</article-title>
            <source>J Glaucoma</source>
            <year>2022</year>
            <month>Jun</month>
            <day>01</day>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>382</fpage>
            <page-range>382-391</page-range>
            <pub-id pub-id-type="pmid">35394456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Laser Trabeculoplasty for Open-Angle Glaucoma: A Systematic Review and Network Meta-Analysis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>229</volume>
            <fpage>301</fpage>
            <page-range>301-313</page-range>
            <pub-id pub-id-type="pmid">32888900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muralidharan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ichhpujani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dhillon</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>Quality of life in glaucoma patients: Comparison of medical therapy, trabeculectomy, and glaucoma drainage device surgery.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>70</volume>
            <issue>12</issue>
            <fpage>4206</fpage>
            <page-range>4206-4211</page-range>
            <pub-id pub-id-type="pmid">36453315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brusini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Papa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Canaloplasty in Pseudoexfoliation Glaucoma. Can It Still Be Considered a Good Choice?</article-title>
            <source>J Clin Med</source>
            <year>2022</year>
            <month>Apr</month>
            <day>30</day>
            <volume>11</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">35566656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rojananuangnit</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jiaranaisilawong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rattanaphaithun</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sathim</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2022</year>
            <volume>16</volume>
            <fpage>4163</fpage>
            <page-range>4163-4178</page-range>
            <pub-id pub-id-type="pmid">36540897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r96">
          <label>96</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Minimally Invasive Glaucoma Surgery</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35881761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Craven</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Giamporcaro</surname>
                <given-names>JE</given-names>
              </name>
              <collab>iStent Study Group</collab>
            </person-group>
            <article-title>Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>8</issue>
            <fpage>1339</fpage>
            <page-range>1339-45</page-range>
            <pub-id pub-id-type="pmid">22814041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>DR</given-names>
              </name>
              <collab>Normal Tension Glaucoma Study</collab>
            </person-group>
            <article-title>Collaborative normal tension glaucoma study.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <page-range>86-90</page-range>
            <pub-id pub-id-type="pmid">12698048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tawfik</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Waisbourd</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Primary angle-closure glaucoma: an update.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2016</year>
            <month>May</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-25</page-range>
            <pub-id pub-id-type="pmid">26119516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bai</surname>
                <given-names>HQ</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>YX</given-names>
              </name>
            </person-group>
            <article-title>Causes and treatments of traumatic secondary glaucoma.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2009</year>
            <season>Mar-Apr</season>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>201</fpage>
            <page-range>201-6</page-range>
            <pub-id pub-id-type="pmid">19253235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r101">
          <label>101</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Musa</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Foster Kennedy Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">35881754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leibowitz</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>The red eye.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>Aug</month>
            <day>03</day>
            <volume>343</volume>
            <issue>5</issue>
            <fpage>345</fpage>
            <page-range>345-51</page-range>
            <pub-id pub-id-type="pmid">10922425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greenfield</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Glaucomatous versus nonglaucomatous optic disc cupping: clinical differentiation.</article-title>
            <source>Semin Ophthalmol</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-108</page-range>
            <pub-id pub-id-type="pmid">10758217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasol</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neuro-ophthalmic disease and optical coherence tomography: glaucoma look-alikes.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>124</fpage>
            <page-range>124-32</page-range>
            <pub-id pub-id-type="pmid">21307679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harwerth</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Quigley</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Visual field defects and retinal ganglion cell losses in patients with glaucoma.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>853</fpage>
            <page-range>853-9</page-range>
            <pub-id pub-id-type="pmid">16769839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22260.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pel&#x0010d;i&#x00107;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ljubi&#x0010d;i&#x00107;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bara&#x00107;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Biuk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rogoi&#x00107;</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma, depression and quality of life: multiple comorbidities, multiple assessments and multidisciplinary plan treatment.</article-title>
            <source>Psychiatr Danub</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>351</fpage>
            <page-range>351-359</page-range>
            <pub-id pub-id-type="pmid">28949316</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
